October 16, 2024
National Institute on Drug Abuse (NIDA)
The purpose of this Notice is to inform potential applicants that effective immediately the National Institute on Drug Abuse (NIDA) will participate in PA-25-080 NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) issued by the National Institutes of Health.
The following text (in italics) has been added to reflect NIDA's participation:
Part 1. Overview Information
Components of Participating Organizations
National Institute on Drug Abuse (NIDA)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.279
All other aspects of the NOFO remain the same.
Please direct all inquiries to:
Yuki Lama, Ph.D
National Institute on Drug Abuse (NIDA)
Phone: 310-443-4577
Email: [email protected]